|
ESC CONGRESS 2019
31 August - 04 September 2019, Paris - France
Session Details
|
Poster Session 6: Acute heart failure
|
Tue 03 Sep
|
08:30 - 12:30
|
European Society of Cardiology
|
Poster Session, Abstract-based Programme
|
Posters - Poster Area
|
Learning Objectives: Posters are on display from 08:30 – 12:30.
Presenters will be by their poster during the coffee break from 10:05 and 10:55 for posters viewing time.
|
Other resources
List of Presentations
Loading...
08:30 | P5405 | Clinical and prognostic relevance of increased liver stiffness coupled with abnormal liver function tests in decompensated heart failure | Anzhela SOLOVEVA (Saint Petersburg, Russian Federation) |
|
08:30 | P5406 | Impact of the albumin level on the prognostic value of diuretic response in patients admitted for acute decompensated heart failure: a prospective study | Kyoko YAMAMOTO (, Japan) |
|
08:30 | P5407 | Body-composition analysis of patients with acute heart failure -preliminary results from the SCALE HF trial- | Fiorangelo DE IESO (Basel, Switzerland) |
|
08:30 | P5408 | Initiating angiotensin receptor blockade and neprilysin inhibitor (ARNI) in acute heart failure with mechanical support | Ho-Tsung HSIN (Banciao, Taiwan) |
|
08:30 | P5409 | Plasma volume status provides the additional prognostic information to the Get With the Guidelines-Heart Failure risk score in acute decompensated heart failure patients | Takahisa YAMADA (Osaka, Japan) |
|
08:30 | P5410 | Combination assessment of renal and hepatic dysfunction improves the predictability of prognosis in patients with acute decompensated heart failure. | Naoki SHIBATA (Nagoya, Japan) |
|
08:30 | P5411 | Prognostic communication with hospitalized heart failure patients; the patients' perspective | Hiroki KITAKATA (Tokyo, Japan) |
|
08:30 | P5412 | Prevalence of RV failure assessed by echocardiography in acute dyspnoea cohort | Kamile CERLINSKAITE (Kaunas, Lithuania) |
|
08:30 | P5413 | Effect of empagliflozin as add-on therapy on serum uric acid level in patients with type 2 diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study | Shunsuke TAMAKI (Osaka, Japan) |
|
|
|
|